Global Stem Cell Umbilical Cord Blood Market-Industry Analysis and forecast 2019 – 2027: By Storage Services, Therapeutics, Application, and Region.

Global Stem Cell Umbilical Cord Blood Market size was valued nearly US$ XX Bn. in 2019 and the total revenue is expected to grow at XX % through 2019 to 2027, reaching nearly US$ 10.02 Bn.   Global Stem Cell Umbilical Cord Blood Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis. Umbilical cord blood is a rich basis of hematopoietic stem cells capable of treating over 80 genetic diseases. Stem cells can also fight long-lasting illnesses like cancer, diabetes, blood disorders and immune diseases. While a small amount of cord blood can be achieved from a single umbilical cord, it comprises a large number of stem cells that can be advanced and stored for forthcoming use. The global market for stem cell umbilical cord blood is expected to gain market growth from 2019 to 2027 because of the growing prevalence of chronic diseases coupled with the developing field of regenerative medicines globally. Also, many government associations and enterprises are supporting the growth of the stem cell umbilical cord blood market. However, competition in the stem cell umbilical cord blood market is intense with key players trying to create brand awareness and market companies are also adopting various market-based strategies. In the U.S., most of the market share is with the three major companies such as Cryo-Cell, Cord Blood Registry (CBR), and ViaCord. The Cord Blood Registry (CBR) has been traded twice, once in 2015 to AMAG Pharmaceuticals for US$ 700 Mn. and again in 2018 to GI Partners for US$ 530 Mn. In Sept 2019, Cord Blood Registry also bought Natera’s Evercord Cord Blood Banking business. Within China, the government controls the industry by allowing only one cord blood bank to drive within each province and authorized government support, and permits are needed. Significantly, the government in China announced in late 2019 that it would be distributing new licenses for the first time, growing from the existing 7 licensed regions for cord blood banking to over 19 regions, with Beijing. The MMR report will also provide an accurate prediction of the contribution of the various segments to the growth of the stem cell umbilical cord blood market size. Based on the storage services, the private cord blood banks segment expected to grow at the highest XX.06% CAGR during the forecast period thanks to technological developments done at the storage services. Also, by application, regenerative medicine is expected to grow at the highest CAGR of XX.15% and is expected to reach a value of US$ XX Mn. by 2027. This is attributed to regenerative medicines in organ transplant to remove the use of immune-suppressing medicines and anti-inflammatory action that are necessary to treat artificial tissues, organ, and bone. North America stem cell umbilical cord blood market was valued US$ XX Mn. in 2019 and is expected to reach a value of US$ XX Mn. by 2027, with a CAGR of XX.20% during the forecast period. This is because of well-developed healthcare sectors, the presence of leading medical diagnostics companies, and the rising number of patients suffering from blood disorders and cancer. Europe accounts for the second-highest revenue share contribution to the global cord blood stem cells market followed by markets in Latin America, Asia Pacific and the Middle East & Africa respectively. Europe accounts for the second highest revenue share followed by markets in South America, APAC and MEA respectively. In recent years, major players in the stem cell umbilical cord blood market have taken several strategic measures, like facility expansions and partnerships. Such as, in 2017, Vita34 Company (Germany) acquired German Company Seracell Pharma to support its position in the German market globally. The MMR reports cover key developments in the stem cell umbilical cord blood market as organic and inorganic growth strategies. For example, in 2018, LifeCell Company, India’s prominent provider of preventive healthcare industry, launched new television commercial to make people conscious about cord stem cells banking. The objective of the report is to present a comprehensive analysis of the Global Stem Cell Umbilical Cord Blood Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Stem Cell Umbilical Cord Blood Market dynamics, structure by analyzing the market segments and projects the Global Stem Cell Umbilical Cord Blood Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Stem Cell Umbilical Cord Blood Market make the report investor’s guide.

Scope of the Global Stem Cell Umbilical Cord Blood Market: Inquire before buying

Global Stem Cell Umbilical Cord Blood Market, By Storage services

• Public Cord Blood Banks • Private Cord Blood Banks • Hybrid Cord Blood Banks

Global Stem Cell Umbilical Cord Blood Market, By Therapeutics

• Cancer • Diabetes • Blood Diseases • Immune Disorders • Metabolic Disorders • Others

Global Stem Cell Umbilical Cord Blood Market, By Application

• Transplant Medicine • Regenerative Medicine

Global Stem Cell Umbilical Cord Blood Market, By Region

• North America o USA o Canada • Europe o UK o France o Germany o Italy o Spain o Norway o Russia • Asia Pacific o China o India o Japan o South Korea o Australia o Malaysia o Indonesia o Vietnam • South America o Mexico o Brazil o Argentina • Middle East and Africa o GCC Countries o South Africa o Nigeria o Egypt

Key players operating in the Global Stem Cell Umbilical Cord Blood Market

• Cordlife Group Limited • Regrow Biosciences Pvt. Ltd. • Cord Blood America • Cryo-Cell International • Medipost • Americord Registry • Esperite • China Cord Blood Corporation • LifeCell Inetrnational • ViaCord • Takara Bio Europe AB • Vita34 AG • Smart Cells International Ltd. • CBR Systems, Inc. • Lifeforce Cryobanks
Global Stem Cell Umbilical Cord Blood Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Stem Cell Umbilical Cord Blood Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Stem Cell Umbilical Cord Blood Market Analysis and Forecast 6.1. Stem Cell Umbilical Cord Blood Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Stem Cell Umbilical Cord Blood Market Analysis and Forecast, By Therapeutics 7.1. Introduction and Definition 7.2. Key Findings 7.3. Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Therapeutics 7.4. Stem Cell Umbilical Cord Blood Market Size (US$ Bn) Forecast, By Therapeutics 7.5. Stem Cell Umbilical Cord Blood Market Analysis, By Therapeutics 7.6. Stem Cell Umbilical Cord Blood Market Attractiveness Analysis, By Therapeutics 8. Global Stem Cell Umbilical Cord Blood Market Analysis and Forecast, By Product 8.1. Introduction and Definition 8.2. Key Findings 8.3. Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Product 8.4. Stem Cell Umbilical Cord Blood Market Size (US$ Bn) Forecast, By Product 8.5. Stem Cell Umbilical Cord Blood Market Analysis, By Product 8.6. Stem Cell Umbilical Cord Blood Market Attractiveness Analysis, By Product 9. Global Stem Cell Umbilical Cord Blood Market Analysis and Forecast, By End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Storage services 9.4. Stem Cell Umbilical Cord Blood Market Size (US$ Bn) Forecast, By Storage services 9.5. Stem Cell Umbilical Cord Blood Market Analysis, By Storage services 9.6. Stem Cell Umbilical Cord Blood Market Attractiveness Analysis, By Storage services 10. Global Stem Cell Umbilical Cord Blood Market Analysis, by Region 10.1. Stem Cell Umbilical Cord Blood Market Value Share Analysis, by Region 10.2. Stem Cell Umbilical Cord Blood Market Size (US$ Bn) Forecast, by Region 10.3. Stem Cell Umbilical Cord Blood Market Attractiveness Analysis, by Region 11. North America Stem Cell Umbilical Cord Blood Market Analysis 11.1. Key Findings 11.2. North America Stem Cell Umbilical Cord Blood Market Overview 11.3. North America Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Therapeutics 11.4. North America Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 11.4.1. Cancer 11.4.2. Diabetes 11.4.3. Blood Diseases 11.4.4. Immune Disorders 11.4.5. Metabolic Disorders 11.4.6. Others 11.5. North America Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Product 11.6. North America Stem Cell Umbilical Cord Blood Market Forecast, By Product 11.6.1. Transplant Medicine 11.6.2. Regenerative Medicine 11.7. North America Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Storage services 11.8. North America Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 11.8.1. Public Cord Blood Banks 11.8.2. Private Cord Blood Banks 11.8.3. Hybrid Cord Blood Banks 11.9. North America Stem Cell Umbilical Cord Blood Market Value Share Analysis, by Country 11.10. North America Stem Cell Umbilical Cord Blood Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Stem Cell Umbilical Cord Blood Market Analysis, by Country 11.12. U.S. Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 11.12.1. Cancer 11.12.2. Diabetes 11.12.3. Blood Diseases 11.12.4. Immune Disorders 11.12.5. Metabolic Disorders 11.12.6. Others 11.13. U.S. Stem Cell Umbilical Cord Blood Market Forecast, By Product 11.13.1. Transplant Medicine 11.13.2. Regenerative Medicine 11.14. U.S. Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 11.14.1. Public Cord Blood Banks 11.14.2. Private Cord Blood Banks 11.14.3. Hybrid Cord Blood Banks 11.15. Canada Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 11.15.1. Cancer 11.15.2. Diabetes 11.15.3. Blood Diseases 11.15.4. Immune Disorders 11.15.5. Metabolic Disorders 11.15.6. Others 11.16. Canada Stem Cell Umbilical Cord Blood Market Forecast, By Product 11.16.1. Transplant Medicine 11.16.2. Regenerative Medicine 11.17. Canada Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 11.17.1. Public Cord Blood Banks 11.17.2. Private Cord Blood Banks 11.17.3. Hybrid Cord Blood Banks 11.18. North America Stem Cell Umbilical Cord Blood Market Attractiveness Analysis 11.18.1. By Therapeutics 11.18.2. By Product 11.18.3. By Storage services 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Stem Cell Umbilical Cord Blood Market Analysis 12.1. Key Findings 12.2. Europe Stem Cell Umbilical Cord Blood Market Overview 12.3. Europe Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Therapeutics 12.4. Europe Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 12.4.1. Cancer 12.4.2. Diabetes 12.4.3. Blood Diseases 12.4.4. Immune Disorders 12.4.5. Metabolic Disorders 12.4.6. Others 12.5. Europe Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Product 12.6. Europe Stem Cell Umbilical Cord Blood Market Forecast, By Product 12.6.1. Transplant Medicine 12.6.2. Regenerative Medicine 12.7. Europe Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Storage services 12.8. Europe Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 12.8.1. Public Cord Blood Banks 12.8.2. Private Cord Blood Banks 12.8.3. Hybrid Cord Blood Banks 12.9. Europe Stem Cell Umbilical Cord Blood Market Value Share Analysis, by Country 12.10. Europe Stem Cell Umbilical Cord Blood Market Forecast, by Country 12.10.1. Germany 12.10.2. UK 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Norway 12.10.7. Russia 12.11. Europe Stem Cell Umbilical Cord Blood Market Analysis, by Country 12.12. Germany Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 12.12.1. Cancer 12.12.2. Diabetes 12.12.3. Blood Diseases 12.12.4. Immune Disorders 12.12.5. Metabolic Disorders 12.12.6. Others 12.13. Germany Stem Cell Umbilical Cord Blood Market Forecast, By Product 12.13.1. Transplant Medicine 12.13.2. Regenerative Medicine 12.14. Germany Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 12.14.1. Public Cord Blood Banks 12.14.2. Private Cord Blood Banks 12.14.3. Hybrid Cord Blood Banks 12.15. U.K. Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 12.15.1. Cancer 12.15.2. Diabetes 12.15.3. Blood Diseases 12.15.4. Immune Disorders 12.15.5. Metabolic Disorders 12.15.6. Others 12.16. U.K. Stem Cell Umbilical Cord Blood Market Forecast, By Product 12.16.1. Transplant Medicine 12.16.2. Regenerative Medicine 12.17. U.K. Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 12.17.1. Public Cord Blood Banks 12.17.2. Private Cord Blood Banks 12.17.3. Hybrid Cord Blood Banks 12.18. France Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 12.18.1. Cancer 12.18.2. Diabetes 12.18.3. Blood Diseases 12.18.4. Immune Disorders 12.18.5. Metabolic Disorders 12.18.6. Others 12.19. France Stem Cell Umbilical Cord Blood Market Forecast, By Product 12.19.1. Transplant Medicine 12.19.2. Regenerative Medicine 12.20. France Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 12.20.1. Public Cord Blood Banks 12.20.2. Private Cord Blood Banks 12.20.3. Hybrid Cord Blood Banks 12.21. Italy Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 12.21.1. Cancer 12.21.2. Diabetes 12.21.3. Blood Diseases 12.21.4. Immune Disorders 12.21.5. Metabolic Disorders 12.21.6. Others 12.22. Italy Stem Cell Umbilical Cord Blood Market Forecast, By Product 12.22.1. Transplant Medicine 12.22.2. Regenerative Medicine 12.23. Italy Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 12.23.1. Public Cord Blood Banks 12.23.2. Private Cord Blood Banks 12.23.3. Hybrid Cord Blood Banks 12.24. Spain Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 12.24.1. Cancer 12.24.2. Diabetes 12.24.3. Blood Diseases 12.24.4. Immune Disorders 12.24.5. Metabolic Disorders 12.24.6. Others 12.25. Spain Stem Cell Umbilical Cord Blood Market Forecast, By Product 12.25.1. Transplant Medicine 12.25.2. Regenerative Medicine 12.26. Spain Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 12.26.1. Public Cord Blood Banks 12.26.2. Private Cord Blood Banks 12.26.3. Hybrid Cord Blood Banks 12.27. Norway Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 12.27.1. Cancer 12.27.2. Diabetes 12.27.3. Blood Diseases 12.27.4. Immune Disorders 12.27.5. Metabolic Disorders 12.27.6. Others 12.28. Norway Stem Cell Umbilical Cord Blood Market Forecast, By Product 12.28.1. Transplant Medicine 12.28.2. Regenerative Medicine 12.29. Norway Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 12.29.1. Public Cord Blood Banks 12.29.2. Private Cord Blood Banks 12.29.3. Hybrid Cord Blood Banks 12.30. Russia Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 12.30.1. Cancer 12.30.2. Diabetes 12.30.3. Blood Diseases 12.30.4. Immune Disorders 12.30.5. Metabolic Disorders 12.30.6. Others 12.31. Russia Stem Cell Umbilical Cord Blood Market Forecast, By Product 12.31.1. Transplant Medicine 12.31.2. Regenerative Medicine 12.32. Russia Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 12.32.1. Public Cord Blood Banks 12.32.2. Private Cord Blood Banks 12.32.3. Hybrid Cord Blood Banks 12.33. Europe Stem Cell Umbilical Cord Blood Market Attractiveness Analysis 12.33.1. By Therapeutics 12.33.2. By Product 12.33.3. By Storage services 12.34. PEST Analysis 12.35. Key Trends 12.36. Key Developments 13. Asia Pacific Stem Cell Umbilical Cord Blood Market Analysis 13.1. Key Findings 13.2. Asia Pacific Stem Cell Umbilical Cord Blood Market Overview 13.3. Asia Pacific Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Therapeutics 13.4. Asia Pacific Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.4.1. Cancer 13.4.2. Diabetes 13.4.3. Blood Diseases 13.4.4. Immune Disorders 13.4.5. Metabolic Disorders 13.4.6. Others 13.5. Asia Pacific Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Product 13.6. Asia Pacific Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.6.1. Transplant Medicine 13.6.2. Regenerative Medicine 13.7. Asia Pacific Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Storage services 13.8. Asia Pacific Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.8.1. Public Cord Blood Banks 13.8.2. Private Cord Blood Banks 13.8.3. Hybrid Cord Blood Banks 13.9. Asia Pacific Stem Cell Umbilical Cord Blood Market Value Share Analysis, by Country 13.10. Asia Pacific Stem Cell Umbilical Cord Blood Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. Malaysia 13.10.7. Indonesia 13.10.8. Vietnam 13.11. Asia Pacific Stem Cell Umbilical Cord Blood Market Analysis, by Country 13.12. China Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.12.1. Cancer 13.12.2. Diabetes 13.12.3. Blood Diseases 13.12.4. Immune Disorders 13.12.5. Metabolic Disorders 13.12.6. Others 13.13. China Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.13.1. Transplant Medicine 13.13.2. Regenerative Medicine 13.14. China Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.14.1. Public Cord Blood Banks 13.14.2. Private Cord Blood Banks 13.14.3. Hybrid Cord Blood Banks 13.15. India Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.15.1. Cancer 13.15.2. Diabetes 13.15.3. Blood Diseases 13.15.4. Immune Disorders 13.15.5. Metabolic Disorders 13.15.6. Others 13.16. India Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.16.1. Transplant Medicine 13.16.2. Regenerative Medicine 13.17. India Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.17.1. Public Cord Blood Banks 13.17.2. Private Cord Blood Banks 13.17.3. Hybrid Cord Blood Banks 13.18. Japan Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.18.1. Cancer 13.18.2. Diabetes 13.18.3. Blood Diseases 13.18.4. Immune Disorders 13.18.5. Metabolic Disorders 13.18.6. Others 13.19. Japan Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.19.1. Transplant Medicine 13.19.2. Regenerative Medicine 13.20. Japan Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.20.1. Public Cord Blood Banks 13.20.2. Private Cord Blood Banks 13.20.3. Hybrid Cord Blood Banks 13.21. South Korea Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.21.1. Cancer 13.21.2. Diabetes 13.21.3. Blood Diseases 13.21.4. Immune Disorders 13.21.5. Metabolic Disorders 13.21.6. Others 13.22. South Korea Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.22.1. Transplant Medicine 13.22.2. Regenerative Medicine 13.23. South Korea Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.23.1. Public Cord Blood Banks 13.23.2. Private Cord Blood Banks 13.23.3. Hybrid Cord Blood Banks 13.24. Australia Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.24.1. Cancer 13.24.2. Diabetes 13.24.3. Blood Diseases 13.24.4. Immune Disorders 13.24.5. Metabolic Disorders 13.24.6. Others 13.25. Australia Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.25.1. Transplant Medicine 13.25.2. Regenerative Medicine 13.26. Australia Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.26.1. Public Cord Blood Banks 13.26.2. Private Cord Blood Banks 13.26.3. Hybrid Cord Blood Banks 13.27. Malaysia Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.27.1. Cancer 13.27.2. Diabetes 13.27.3. Blood Diseases 13.27.4. Immune Disorders 13.27.5. Metabolic Disorders 13.27.6. Others 13.28. Malaysia Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.28.1. Transplant Medicine 13.28.2. Regenerative Medicine 13.29. Malaysia Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.29.1. Public Cord Blood Banks 13.29.2. Private Cord Blood Banks 13.29.3. Hybrid Cord Blood Banks 13.30. Indonesia Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.30.1. Cancer 13.30.2. Diabetes 13.30.3. Blood Diseases 13.30.4. Immune Disorders 13.30.5. Metabolic Disorders 13.30.6. Others 13.31. Indonesia Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.31.1. Transplant Medicine 13.31.2. Regenerative Medicine 13.32. Indonesia Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.32.1. Public Cord Blood Banks 13.32.2. Private Cord Blood Banks 13.32.3. Hybrid Cord Blood Banks 13.33. Vietnam Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 13.33.1. Cancer 13.33.2. Diabetes 13.33.3. Blood Diseases 13.33.4. Immune Disorders 13.33.5. Metabolic Disorders 13.33.6. Others 13.34. Vietnam Stem Cell Umbilical Cord Blood Market Forecast, By Product 13.34.1. Transplant Medicine 13.34.2. Regenerative Medicine 13.35. Vietnam Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 13.35.1. Public Cord Blood Banks 13.35.2. Private Cord Blood Banks 13.35.3. Hybrid Cord Blood Banks 13.36. Asia Pacific Stem Cell Umbilical Cord Blood Market Attractiveness Analysis 13.36.1. By Therapeutics 13.36.2. By Product 13.36.3. By Storage services 13.37. PEST Analysis 13.38. Key Trends 13.39. Key Developments 14. Middle East & Africa Stem Cell Umbilical Cord Blood Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Stem Cell Umbilical Cord Blood Market Overview 14.3. Middle East & Africa Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Therapeutics 14.4. Middle East & Africa Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 14.4.1. Cancer 14.4.2. Diabetes 14.4.3. Blood Diseases 14.4.4. Immune Disorders 14.4.5. Metabolic Disorders 14.4.6. Others 14.5. Middle East & Africa Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Product 14.6. Middle East & Africa Stem Cell Umbilical Cord Blood Market Forecast, By Product 14.6.1. Transplant Medicine 14.6.2. Regenerative Medicine 14.7. Middle East & Africa Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Storage services 14.8. Middle East & Africa Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 14.8.1. Public Cord Blood Banks 14.8.2. Private Cord Blood Banks 14.8.3. Hybrid Cord Blood Banks 14.9. Middle East & Africa Stem Cell Umbilical Cord Blood Market Value Share Analysis, by Country 14.10. Middle East & Africa Stem Cell Umbilical Cord Blood Market Forecast, by Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.11. Middle East & Africa Stem Cell Umbilical Cord Blood Market Analysis, by Country 14.12. GCC Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 14.12.1. Cancer 14.12.2. Diabetes 14.12.3. Blood Diseases 14.12.4. Immune Disorders 14.12.5. Metabolic Disorders 14.12.6. Others 14.13. GCC Stem Cell Umbilical Cord Blood Market Forecast, By Product 14.13.1. Transplant Medicine 14.13.2. Regenerative Medicine 14.14. GCC Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 14.14.1. Public Cord Blood Banks 14.14.2. Private Cord Blood Banks 14.14.3. Hybrid Cord Blood Banks 14.15. South Africa Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 14.15.1. Cancer 14.15.2. Diabetes 14.15.3. Blood Diseases 14.15.4. Immune Disorders 14.15.5. Metabolic Disorders 14.15.6. Others 14.16. South Africa Stem Cell Umbilical Cord Blood Market Forecast, By Product 14.16.1. Transplant Medicine 14.16.2. Regenerative Medicine 14.17. South Africa Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 14.17.1. Public Cord Blood Banks 14.17.2. Private Cord Blood Banks 14.17.3. Hybrid Cord Blood Banks 14.18. Nigeria Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 14.18.1. Cancer 14.18.2. Diabetes 14.18.3. Blood Diseases 14.18.4. Immune Disorders 14.18.5. Metabolic Disorders 14.18.6. Others 14.19. Nigeria Stem Cell Umbilical Cord Blood Market Forecast, By Product 14.19.1. Transplant Medicine 14.19.2. Regenerative Medicine 14.20. Nigeria Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 14.20.1. Public Cord Blood Banks 14.20.2. Private Cord Blood Banks 14.20.3. Hybrid Cord Blood Banks 14.21. Egypt Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 14.21.1. Cancer 14.21.2. Diabetes 14.21.3. Blood Diseases 14.21.4. Immune Disorders 14.21.5. Metabolic Disorders 14.21.6. Others 14.22. Egypt Stem Cell Umbilical Cord Blood Market Forecast, By Product 14.22.1. Transplant Medicine 14.22.2. Regenerative Medicine 14.23. Egypt Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 14.23.1. Public Cord Blood Banks 14.23.2. Private Cord Blood Banks 14.23.3. Hybrid Cord Blood Banks 14.24. Middle East & Africa Stem Cell Umbilical Cord Blood Market Attractiveness Analysis 14.24.1. By Therapeutics 14.24.2. By Product 14.24.3. By Storage services 14.25. PEST Analysis 14.26. Key Trends 14.27. Key Developments 15. South America Stem Cell Umbilical Cord Blood Market Analysis 15.1. Key Findings 15.2. South America Stem Cell Umbilical Cord Blood Market Overview 15.3. South America Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Therapeutics 15.4. South America Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 15.4.1. Cancer 15.4.2. Diabetes 15.4.3. Blood Diseases 15.4.4. Immune Disorders 15.4.5. Metabolic Disorders 15.4.6. Others 15.5. South America Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Product 15.6. South America Stem Cell Umbilical Cord Blood Market Forecast, By Product 15.6.1. Transplant Medicine 15.6.2. Regenerative Medicine 15.7. South America Stem Cell Umbilical Cord Blood Market Value Share Analysis, By Storage services 15.8. South America Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 15.8.1. Public Cord Blood Banks 15.8.2. Private Cord Blood Banks 15.8.3. Hybrid Cord Blood Banks 15.9. South America Stem Cell Umbilical Cord Blood Market Value Share Analysis, by Country 15.10. South America Stem Cell Umbilical Cord Blood Market Forecast, by Country 15.10.1. Mexico 15.10.2. Brazil 15.10.3. Argentina 15.11. South America Stem Cell Umbilical Cord Blood Market Analysis, by Country 15.12. Brazil Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 15.12.1. Cancer 15.12.2. Diabetes 15.12.3. Blood Diseases 15.12.4. Immune Disorders 15.12.5. Metabolic Disorders 15.12.6. Others 15.13. Brazil Stem Cell Umbilical Cord Blood Market Forecast, By Product 15.13.1. Transplant Medicine 15.13.2. Regenerative Medicine 15.14. Brazil Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 15.14.1. Public Cord Blood Banks 15.14.2. Private Cord Blood Banks 15.14.3. Hybrid Cord Blood Banks 15.15. Mexico Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 15.15.1. Cancer 15.15.2. Diabetes 15.15.3. Blood Diseases 15.15.4. Immune Disorders 15.15.5. Metabolic Disorders 15.15.6. Others 15.16. Mexico Stem Cell Umbilical Cord Blood Market Forecast, By Product 15.16.1. Transplant Medicine 15.16.2. Regenerative Medicine 15.17. Mexico Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 15.17.1. Public Cord Blood Banks 15.17.2. Private Cord Blood Banks 15.17.3. Hybrid Cord Blood Banks 15.18. Argentina Stem Cell Umbilical Cord Blood Market Forecast, By Therapeutics 15.18.1. Cancer 15.18.2. Diabetes 15.18.3. Blood Diseases 15.18.4. Immune Disorders 15.18.5. Metabolic Disorders 15.18.6. Others 15.19. Argentina Stem Cell Umbilical Cord Blood Market Forecast, By Product 15.19.1. Transplant Medicine 15.19.2. Regenerative Medicine 15.20. Argentina Stem Cell Umbilical Cord Blood Market Forecast, By Storage services 15.20.1. Public Cord Blood Banks 15.20.2. Private Cord Blood Banks 15.20.3. Hybrid Cord Blood Banks 15.21. South America Stem Cell Umbilical Cord Blood Market Attractiveness Analysis 15.21.1. By Therapeutics 15.21.2. By Product 15.21.3. By Storage services 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Cordlife Group Limited 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Regrow Biosciences Pvt. Ltd. 16.3.3. Cord Blood America 16.3.4. Cryo-Cell International 16.3.5. Medipost 16.3.6. Americord Registry 16.3.7. Esperite 16.3.8. China Cord Blood Corporation 16.3.9. LifeCell Inetrnational 16.3.10. ViaCord 16.3.11. Takara Bio Europe AB 16.3.12. Vita34 AG 16.3.13. Smart Cells International Ltd. 16.3.14. CBR Systems, Inc. 16.3.15. Lifeforce Cryobanks 17. Primary Key Insights

About This Report

Report ID 72065
Category Healthcare
Published Date September 2020
Updated Date
Contact Us